You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Geographic Atrophy: Expert Perspectives and Latest Data

  • Authors: Robyn Guymer, MBBS, PhD; Frank G. Holz, MD; Giovanni Staurenghi, MD; Adnan Tufail, MD, FRCOphth; Patricia Udaondo, MD, PhD
  • CME Released: 12/12/2022
  • Valid for credit through: 12/12/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for an international audience of non-US ophthalmologists, eyecare professionals, and all physicians who care for patients with age-related macular degeneration (AMD).

The goal of this activity is for learners to be better able to assess patients with AMD and identify patients who might benefit from emerging therapies according to latest evidence.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Latest data for emerging GA therapies
    • Characteristic features of atrophy on optical coherence tomography and autofluorescence
    • Assessment of GA in clinical practice
    • Monitoring of patients with GA


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Robyn Guymer, MBBS, PhD

    Deputy Director
    Centre for Eye Research Australia
    Professor of Surgery (Ophthalmology)
    University of Melbourne
    Melbourne, Australia

    Disclosures

    Robyn Guymer, MBBS, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Apellis; Bayer AG; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Roche
    Speaker or member of speakers bureau for: Apellis; Bayer AG; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Roche
    Research funding from: Apellis

  • Frank G. Holz, MD

    Chairman
    Department of Ophthalmology
    University of Bonn
    Bonn, Germany

    Disclosures

    Frank G. Holz, MD, has the following relevant financial relationships:
    Consultant or advisor for: Acucela Inc.; Apellis; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bioeq/Formycon; Genentech, Inc./Roche; Geuder; Grayburg; Gyroscope; Heidelberg Engineering; IvericBio; Kanghong; LinBioscience; Novartis Pharmaceuticals Corporation; Oxurion; Pixium Vision; Stealth BioTherapeutics; Zeiss
    Research funding from: Acucela Inc.; Allergan, Inc.; Bayer AG; Bioeq/Formycon; Center Vue; Genentech, Inc./Roche; Heidelberg Engineering; Kanghong; Night Star; Novartis Pharmaceuticals Corporation; Optos; Pixium Vision; Zeiss

  • Giovanni Staurenghi, MD

    Professor of Ophthalmology
    University of Milan
    Milan, Italy

    Disclosures

    Giovanni Staurenghi, MD, has the following relevant financial relationships:
    Consultant or advisor for: Annexon; Apellis; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Carl Zeiss Meditec; Centervue; Endogena; Genentech, Inc.; Heidelberg Engineering; Kyowa Kirin Inc.; Novartis Pharmaceuticals Corporation; Optos; Ora, Inc.; Roche; RetinAi; SIMR Biotechnology Co.
    Speaker or member of speakers bureau for: Allergan, Inc.; Bayer AG; Carl Zeiss Meditec; Centervue; Heidelberg Engineering; Novartis Pharmaceuticals Corporation; Roche
    Research funding from: Allergan, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Carl Zeiss Meditec; Centervue; Genentech, Inc.; Heidelberg Engineering; Novartis Pharmaceuticals Corporation; Optos; Optovue, Inc.; Quantel Medical; Roche; Topcon
    Royalties from: Ocular Instruments
    Patent beneficiary of: Scanning laser ophthalmoscope lenses (Staurenghi 230 and Staurenghi 290) for Ocular Instruments

  • Adnan Tufail, MD, FRCOphth

    Professor of Ophthalmology
    University College London Institute of Ophthalmology
    Consultant Ophthalmologist
    Moorfields Eye Hospital
    London, United Kingdom

    Disclosures

    Adnan Tufail, MD, FRCOphth, has the following relevant financial relationships:
    Consultant or advisor for: Apellis; Allergan, Inc.; Annexon; Bayer AG; Genentech, Inc.; Iveric Bio; Novartis Pharmaceuticals Corporation; Oxurion; Roche; Thea
    Speaker or member of speakers bureau for: Apellis; Thea
    Research funding from: Bayer AG; Novartis Pharmaceuticals Corporation
    Ownership interest: Oculogics (pre-clinical early development only)

  • Patricia Udaondo, MD, PhD

    Medical Director
    Aiken Ophthalmological Clinic
    Retina Specialist
    University and Polytechnic Hospital La Fe
    Valencia, Spain

    Disclosures

    Patricia Udaondo, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie Inc.; Alimera; Apellis; Bayer
    Speaker or member of speakers bureau for: AbbVie; Alimera Sciences; Apellis; Bayer AG; Novartis Pharmaceuticals Corporation

Editors

  • Katherine Carpenter, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Katherine Carpenter, PhD, has the following relevant financial relationships
    Advisor or consultant for: Eisai Inc. (former); GW Pharmaceuticals (former)

  • Lorena Casadonte, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Lorena Casadonte, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Geographic Atrophy: Expert Perspectives and Latest Data

Authors: Robyn Guymer, MBBS, PhD; Frank G. Holz, MD; Giovanni Staurenghi, MD; Adnan Tufail, MD, FRCOphth; Patricia Udaondo, MD, PhDFaculty and Disclosures

CME Released: 12/12/2022

Valid for credit through: 12/12/2023

processing....

Transcription en français

Download the pdf.

 

« Return to: Geographic Atrophy: Expert Perspectives and Latest Data
  • Print